Editorial: golimumab dosing intensification effective in ulcerative colitis with no need for therapeutic drug monitoring. Hanzel J, Drobne D. Aliment Pharmacol Ther 2023;57:1469-1470.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hanzel J, Drobne D. Editorial: golimumab dosing intensification effective in ulcerative colitis with no need for therapeutic drug monitoring. Aliment Pharmacol Ther 2023;57:1469-1470.
PMID: 37243472